Found: 12
Select item for more details and to access through your institution.
Clinical and microbiological impact of long‐term discontinuation of fluoroquinolone prophylaxis in haematological patients with prolonged profound neutropenia.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 377, doi. 10.1111/ejh.13670
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 299, doi. 10.1111/ejh.13449
- Publication type:
- Article
TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study).
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 364, doi. 10.1111/ejh.13674
- By:
- Publication type:
- Article
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 354, doi. 10.1111/ejh.13673
- By:
- Publication type:
- Article
Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 343, doi. 10.1111/ejh.13672
- By:
- Publication type:
- Article
A descriptive cost‐analysis of MYX.1/MCRN003, a phase 2 clinical trial evaluating high‐dose weekly carfilzomib, cyclophosphamide, and dexamethasone in relapsed and refractory multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 333, doi. 10.1111/ejh.13671
- By:
- Publication type:
- Article
Radiation‐free myeloablative conditioning consisting of fludarabine added to full‐dose busulfan and cyclophosphamide in single‐unit cord blood transplantation for adults.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 374, doi. 10.1111/ejh.13669
- By:
- Publication type:
- Article
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 301, doi. 10.1111/ejh.13649
- By:
- Publication type:
- Article
Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 324, doi. 10.1111/ejh.13668
- By:
- Publication type:
- Article
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 370, doi. 10.1111/ejh.13667
- By:
- Publication type:
- Article
Baseline serum B‐cell maturation antigen levels predict time to disease progression for patients with smoldering multiple myeloma.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 318, doi. 10.1111/ejh.13666
- By:
- Publication type:
- Article
Healthcare‐associated blood stream infections in hematological patients in Finland during the years 2006‐2016.
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 311, doi. 10.1111/ejh.13663
- By:
- Publication type:
- Article